Effect of Glucuronosyltransferase (UGT) Genetic Variation on Pharmacokinetics of Empagliflozin

Sponsor
Ain Shams University
Study ID
NCT05036421
Phase
PHASE3
Status
Completed

Conditions

  • Pharmacogenomic
  • Pharmacokinetics

Eligibility Criteria

Sex
MALE
Age
18 Years - 45 Years
Healthy Volunteers
Accepted

Interventions

Study Details

The aim of this works is to investigate the effect of genetic polymorphism of snps on human response to treatment with empagliflozin and its correlation with with pharmacokinetic parameters in Egyptian subjects

Key Dates

Start date
Feb 15, 2022
Status verified
Feb 2023
Primary completion
May 20, 2022
Completion
May 20, 2022

Study Design

Enrollment
18 participants (actual)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER

Arms

  • Experimental: Study Group
    Empagliflozin

Primary Outcome Measure

Pharmacokinetic parameters [ Time Frame: 48 hours ]

Related Studies